These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35504427)

  • 61. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preparation and characterization of methylene blue nanoparticles for Alzheimer's disease and other tauopathies.
    Jinwal UK; Groshev A; Zhang J; Grover A; Sutariya VB
    Curr Drug Deliv; 2014; 11(4):541-50. PubMed ID: 24237400
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer's Disease.
    Xu R; Wang J; Xu J; Song X; Huang H; Feng Y; Fu C
    Int J Nanomedicine; 2020; 15():1149-1160. PubMed ID: 32110013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles.
    Liu Y; Huang R; Han L; Ke W; Shao K; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Sep; 30(25):4195-202. PubMed ID: 19467700
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier.
    Baghirov H; Karaman D; Viitala T; Duchanoy A; Lou YR; Mamaeva V; Pryazhnikov E; Khiroug L; de Lange Davies C; Sahlgren C; Rosenholm JM
    PLoS One; 2016; 11(8):e0160705. PubMed ID: 27547955
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution.
    Vilella A; Tosi G; Grabrucker AM; Ruozi B; Belletti D; Vandelli MA; Boeckers TM; Forni F; Zoli M
    J Control Release; 2014 Jan; 174():195-201. PubMed ID: 24316476
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Lin PI; Wang CC
    Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protein-functionalized nanoparticles derived from end-functional polymers and polymer prodrugs for crossing the blood-brain barrier.
    Cox A; Vinciguerra D; Re F; Magro RD; Mura S; Masserini M; Couvreur P; Nicolas J
    Eur J Pharm Biopharm; 2019 Sep; 142():70-82. PubMed ID: 31176723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
    J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
    Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
    J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.
    Kulkarni SA; Feng SS
    Pharm Res; 2013 Oct; 30(10):2512-22. PubMed ID: 23314933
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Crossing the blood-brain barrier with nanoparticles.
    Zhou Y; Peng Z; Seven ES; Leblanc RM
    J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
    [TBL] [Abstract][Full Text] [Related]  

  • 75. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
    Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Mbimba T; Bui T; Harrison K; Sutariya V
    J Drug Target; 2011 Nov; 19(9):837-45. PubMed ID: 21692650
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.
    Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B
    Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin.
    Akel H; Csóka I; Ambrus R; Bocsik A; Gróf I; Mészáros M; Szecskó A; Kozma G; Veszelka S; Deli MA; Kónya Z; Katona G
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948054
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability.
    Rabanel JM; Piec PA; Landri S; Patten SA; Ramassamy C
    J Control Release; 2020 Dec; 328():679-695. PubMed ID: 32979453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anthropogenic Iron Oxide Nanoparticles Induce Damage to Brain Microvascular Endothelial Cells Forming the Blood-Brain Barrier.
    Gárate-Vélez L; Escudero-Lourdes C; Salado-Leza D; González-Sánchez A; Alvarado-Morales I; Bahena D; Labrada-Delgado GJ; Rodríguez-López JL
    J Alzheimers Dis; 2020; 76(4):1527-1539. PubMed ID: 32716353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.